Actuate Therapeutics (ACTU) Earnings Date & Reports

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3)... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACTU is expected to report earnings to fall 40.00% to -18 cents per share on December 03

Actuate Therapeutics ACTU Stock Earnings Reports

Q3'25

Est.

$-0.18

Q2'25

Missed

by $0.11

The last earnings report on September 03 showed earnings per share of -30 cents, missing the estimate of -18 cents. With 76.48K shares outstanding, the current market capitalization sits at 170.94M.

View a ticker or compare two or three

Compare

ACTU

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ACTU
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ACTU showed earnings on September 03, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details